Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$5.31
NASDAQLPCN
Open
$5.33
Change
$0.11 (2.12%)
Day's Range
$5.00 - $5.40
52-Week Range
$2.40 - $11.79
Volume
32.6K
Market Cap
$28.4M